Who Owns Sonoma Pharmaceuticals Stock?
NASDAQ: SNOAHealthcareDrug Manufacturers - Specialty & GenericUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 2.31%
- Held by insiders
- 0.42%
- Institutional holders
- 15
- Institutions 2.3%
- Insiders 0.4%
- Public and other 97.3%
Who owns Sonoma Pharmaceuticals stock?
Institutional investors own about 2.3% of Sonoma Pharmaceuticals's shares, spread across 15 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 0.42% of SNOA.
The largest institutional holders are Renaissance Technologies, LLC (0.85%), Geode Capital Management, LLC (0.56%) and Vanguard Capital Management LLC (0.39%). Together, the top 10 institutions control 2.3% of shares outstanding. In their latest filings, 5 of the top 10 institutions increased their SNOA positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of SNOA
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Renaissance Technologies, LLC | 40.47K | 0.85% | +100.0% |
| Geode Capital Management, LLC | 26.79K | 0.56% | +34.3% |
| Vanguard Capital Management LLC | 18.79K | 0.39% | 0.0% |
| McKinley Carter Wealth Services, Inc. | 11.19K | 0.23% | 0.0% |
| UBS Group AG | 7.81K | 0.16% | +130033.3% |
| Global Retirement Partners, LLC | 2.55K | 0.05% | +230.1% |
| Morgan Stanley | 2.00K | 0.04% | -0.2% |
| Osaic Holdings Inc. | 500 | 0.01% | 0.0% |
| Barclays Plc | 459 | 0.01% | +100.0% |
| Blackrock Inc. | 113 | 0.00% | 0.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of SNOA
| Fund | Shares | % Held |
|---|---|---|
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 20.91K | 0.44% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 18.79K | 0.39% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 2.53K | 0.05% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 2.31K | 0.05% |
Frequently asked questions
Who is the largest shareholder of Sonoma Pharmaceuticals?
Renaissance Technologies, LLC is the largest institutional shareholder of SNOA, owning 0.85% of shares outstanding (40.47K shares) as of its latest 13F filing.
What percentage of Sonoma Pharmaceuticals is owned by institutions?
Institutions own about 2.3% of SNOA shares and 2.3% of the public float.
How much of Sonoma Pharmaceuticals do insiders own?
Insiders, such as officers and directors, own about 0.42% of SNOA shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.